1. Home
  2. EVOK vs WNW Comparison

EVOK vs WNW Comparison

Compare EVOK & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • WNW
  • Stock Information
  • Founded
  • EVOK 2007
  • WNW 2015
  • Country
  • EVOK United States
  • WNW China
  • Employees
  • EVOK N/A
  • WNW N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • EVOK Health Care
  • WNW Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • WNW Nasdaq
  • Market Cap
  • EVOK 4.2M
  • WNW 4.4M
  • IPO Year
  • EVOK 2013
  • WNW 2020
  • Fundamental
  • Price
  • EVOK $2.59
  • WNW $1.97
  • Analyst Decision
  • EVOK
  • WNW
  • Analyst Count
  • EVOK 0
  • WNW 0
  • Target Price
  • EVOK N/A
  • WNW N/A
  • AVG Volume (30 Days)
  • EVOK 16.5K
  • WNW 6.6M
  • Earning Date
  • EVOK 05-13-2025
  • WNW 11-15-2024
  • Dividend Yield
  • EVOK N/A
  • WNW N/A
  • EPS Growth
  • EVOK N/A
  • WNW N/A
  • EPS
  • EVOK N/A
  • WNW N/A
  • Revenue
  • EVOK $10,249,415.00
  • WNW $380,345.00
  • Revenue This Year
  • EVOK $58.84
  • WNW N/A
  • Revenue Next Year
  • EVOK $58.11
  • WNW N/A
  • P/E Ratio
  • EVOK N/A
  • WNW N/A
  • Revenue Growth
  • EVOK 97.84
  • WNW N/A
  • 52 Week Low
  • EVOK $1.94
  • WNW $0.95
  • 52 Week High
  • EVOK $12.32
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 47.70
  • WNW 46.03
  • Support Level
  • EVOK $2.02
  • WNW $0.95
  • Resistance Level
  • EVOK $2.53
  • WNW $2.95
  • Average True Range (ATR)
  • EVOK 0.22
  • WNW 0.30
  • MACD
  • EVOK 0.10
  • WNW 0.22
  • Stochastic Oscillator
  • EVOK 97.01
  • WNW 51.00

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.

Share on Social Networks: